Upadacitinib Des Tosyl Impurity
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

1708997- 43-6Upadacitinib Des Tosyl Impurity

● 재고 있음

카탈로그 번호:VE0027851
CAS 번호:1708997- 43-6
분자식:C14H17N5
분자량:255.32 g/mol

에 대한 추가 정보 CAS 1708997- 43-6

모약물

Upadacitinib

IUPAC명

8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3H-imidazo[1,2-a] pyrrolo[2,3-e] pyrazine

Pharmacopeial Synonyms

N/A

동의어

N/A

SMILES

CC[C@H]1[C@@H](C2=CN=C3C=NC(NC=C4)=C4N32)CNC1

InChI

InChI=1S/C14H17N5/c1-2-9-5-15-6-10(9)12-7-17-13-8-18-14-11(19(12)13)3-4-16-14/h3-4,7-10,15-16H,2,5-6H2,1H3/t9-,10+/m1/s1

설명

Upadacitinib Des Tosyl Impurity (CAS 1708997-43-6) is a structurally related process impurity arising from incomplete tosyl protection removal during upadacitinib synthesis. It is characterized by mass spectrometry and retention behavior consistent with des-tosylated analogs and commonly monitored by validated HPLC and LC-MS methods to support impurity profiling and batch release. Typical control measures include reaction optimization, purification by crystallization or preparative chromatography, and specification limits defined per ICH Q3A guidelines. Stability studies assess its formation under thermal and hydrolytic stress, while accurate quantitation at low ppm levels is critical to ensure API purity and regulatory compliance.

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url